4.5 Article

Synthesis and characterization of injectable, thermosensitive, and biocompatible acellular bone matrix/poly(ethylene glycol)-poly (ε-caprolactone)-poly(ethylene glycol) hydrogel composite

Journal

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Volume 100A, Issue 1, Pages 171-179

Publisher

WILEY
DOI: 10.1002/jbm.a.33262

Keywords

injectable; thermosensitive; acellular bone matrix; hydrogel; biocompatible

Funding

  1. National 863 Project [2007AA021902]
  2. New Century Excellent Talents in University [NCET-08-0371]

Ask authors/readers for more resources

In orthopedic tissue engineering, the extensively applied acellular bone matrix (ABM) can seldom be prefabricated just right to mold the cavity of the diverse defects, might induce severe inflammation on account of the migration of small granules and usually bring the patients great pain in the treatment. In this study, a new injectable thermosensitive ABM/PECE composite with good biocompatibility was designed and prepared by adding the ABM granules into the triblock copolymer poly(ethylene eglycol)-poly(epsilon-caprolactone)-poly(ethylene eglycol) (PEG-PCL-PEG, PECE). The PECE was synthesized by ring-opening copolymerization and characterized by H-1 NMR. The ABM was prepared by acellular treatment of natural bone and ground to fine granules. The obtained ABM/PECE composite showed the most important absorption bands of ABM and PECE copolymer in FT-IR spectroscopy and underwent sol-gel phage transition from solution to nonflowing hydrogel at 37 degrees C. SEM results indicated that the ABM/PECE composite with different ABM contents all presented similar porous 3D structure. ABM/PECE composite presented mild cytotoxicity to rat MSCs in vitro and good biocompatibility in the BALB/c mice subcutis up to 4 weeks. In conclusion, all the results confirmed that the injectable thermosensitive ABM/PECE composite was a promising candidate for orthopedic tissue engineering in a minimally-invasive way. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 171-179, 2012.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis

Yu Fan, Lijia He, Yu Wang, Shaozhi Fu, Yunwei Han, Juan Fan, Qinglian Wen

Summary: CLIP4 is downregulated in breast cancer and correlated with hormone receptor status and breast cancer grading. Its expression is positively associated with basal-like and triple negative breast cancer status, and ectopic expression is linked to poor prognosis. Analysis of genes co-expressed with CLIP4 revealed enrichment of multiple signaling pathways in the high expression phenotype.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Oncology

Intratumoral Injection of Anlotinib Hydrogel Combined With Radiotherapy Reduces Hypoxia in Lewis Lung Carcinoma Xenografts: Assessment by Micro Fluorine-18-fluoromisonidazole Positron Emission Tomography/Computed Tomography Hypoxia Imaging

Qin Gao, YiQing Jiang, XiaoJie Li, Hui Chen, Shan Tang, Han Chen, XiangXiang Shi, Yue Chen, ShaoZhi Fu, Sheng Lin

Summary: The study investigated the effects of intratumoral injections of anlotinib hydrogel combined with radiotherapy on tumor hypoxia, finding that it could inhibit vascular growth, alleviate hypoxia, reduce toxicity, and prolong survival in mice. Furthermore, RT+AL-HA-Tyr reduced HIF-1α, Ki67, and VEGF-A expression, and increased gamma-H2AX levels in tumor cells.

FRONTIERS IN ONCOLOGY (2021)

Article Materials Science, Biomaterials

Therapeutic effects of EGF-modified curcumin/chitosan nano-spray on wound healing

Yue Li, QingQing Leng, XianLun Pang, Huan Shi, YanLin Liu, SuSu Xiao, Ling Zhao, Ping Zhou, ShaoZhi Fu

Summary: A novel nano-drug delivery system, EGF@CCN, was developed for treating skin defects, showing significant advantages in promoting wound healing. The prepared nano-scaled EGF@CCN spray represents a promising strategy for the treatment of dermal wounds.

REGENERATIVE BIOMATERIALS (2021)

Review Cell Biology

Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression

Jing Jin, Yi Li, Qijie Zhao, Yue Chen, Shaozhi Fu, JingBo Wu

Summary: Recent studies have shown that tumor microenvironment (TME) immune cells play a significant role in affecting the development and progression of breast cancer, but lack of sufficient evidence limits the clinical application of immunotherapy for advanced and metastatic breast cancers. Targeting STAT3 and/or combining it with radiotherapy may enhance anti-cancer immune responses and rescue the systemic immunologic microenvironment in breast cancer.STAT3 function in TME of breast cancer involves multiple types of immunosuppression and is associated with tumor cell metastasis, in addition to its oncogenic role in tumor cells.

CELL COMMUNICATION AND SIGNALING (2021)

Article Pharmacology & Pharmacy

Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer

Jing Wang, Yan Zhang, GuangPeng Zhang, Li Xiang, HaoWen Pang, Kang Xiong, Yun Lu, JianMei Li, Jie Dai, Sheng Lin, ShaoZhi Fu

Summary: This study demonstrates promising clinical application of radiotherapy in combination with EGF@DOX-NPs for lung cancer treatment. The targeted nanoparticles selectively accumulate at the tumor site due to radiation-induced outburst of local intra-tumoral blood vessels. Compared with DOX alone, EGF@DOX-NPs significantly decrease tumor cell viability and migration, and increase apoptosis rates. Moreover, EGF@DOX-NPs increase survival of tumor-bearing mice through radiation-induced aggregation without apparent systemic toxic effects. Therefore, the combination of radiotherapy and EGF@DOX-NPs shows potential for improving clinical outcomes in lung cancer treatment.

DRUG DELIVERY (2022)

Article Chemistry, Multidisciplinary

Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer

Ping Chen, Xu Zhang, Renbo Ding, Linglin Yang, Xueying Lyu, Jianming Zeng, Josh Haipeng Lei, Lijian Wang, Jiong Bi, Nan Shao, Ditian Shu, Bin Wu, Jingbo Wu, Zhihui Yang, Haiyan Wang, Biqiong Wang, Kang Xiong, Yun Lu, Shaozhi Fu, Tak Kan Choi, Ng Wai Lon, Aiping Zhang, Dongyang Tang, Yingyao Quan, Ya Meng, Kai Miao, Heng Sun, Ming Zhao, Jiaolin Bao, Lei Zhang, Xiaoling Xu, Yanxia Shi, Ying Lin, Chuxia Deng

Summary: This study discusses the development of patient-derived organoids (PDOs) as a real-time platform to explore tailored treatment options for refractory breast cancers. PDOs successfully generated from breast cancer tissues reflect previous treatment responses of corresponding patients. Patients deemed sensitive to at least one drug by PDOs showed good treatment responses in clinical case studies.

ADVANCED SCIENCE (2021)

Review Oncology

Therapeutic Plasma Exchange: For Cancer Patients

Yuru Hu, Hanshan Yang, Shaozhi Fu, Jingbo Wu

Summary: Therapeutic plasma exchange is a trial method used for cancer treatment by removing pathogenic factors in the plasma. Despite bringing new hope for cancer treatment, the evidence supporting therapeutic plasma exchange is controversial, and more well-designed prospective trials are needed to define its role in cancer treatment.

CANCER MANAGEMENT AND RESEARCH (2022)

Article Engineering, Environmental

Anaerobic bacteria mediated 'smart missile' targeting tumor hypoxic area enhances the therapeutic outcome of lung cancer

Yue Li, Qingqing Leng, Yan Zhang, Sheng Lin, Qinglian Wen, Yun Lu, Kang Xiong, Huan Shi, Yanlin Liu, Susu Xiao, Ling Zhao, Jingbo Wu, Zhiyong Qian, Shaozhi Fu

Summary: Tumor hypoxia negatively affects the clinical treatment of lung cancer. This study proposes a novel drug delivery strategy by implanting anaerobic Bifidobacterium infantis as a preimplanted target and using bacterial antibody decorated nano-drug missiles to enrich therapeutic drugs in the tumor hypoxic area. The study confirms the excellent anti-tumor effect of this strategy, with reduced systemic side effects. This work provides an elegant platform for in vivo delivery of chemotherapeutic drugs to the hypoxic area of solid tumors.

CHEMICAL ENGINEERING JOURNAL (2022)

Article Nanoscience & Nanotechnology

The Effects of a Novel Curcumin Derivative Loaded Long-Circulating Solid Lipid Nanoparticle on the MHCC-97H Liver Cancer Cells and Pharmacokinetic Behavior

Yumeng Wei, Ke Li, Wenmei Zhao, Yingmeng He, Hongping Shen, Jiyuan Yuan, Chao Pi, Xiaomei Zhang, Mingtang Zeng, Shaozhi Fu, Xinjie Song, Robert J. Lee, Ling Zhao

Summary: This study successfully developed long-circulating solid lipid nanoparticles containing a novel curcumin derivative and demonstrated their favorable pharmacokinetics and anti-cancer effects in treating MHCC-97H liver cancer cells.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

Article Biotechnology & Applied Microbiology

Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer

Susu Xiao, Huan Shi, Yan Zhang, Yu Fan, Li Wang, Li Xiang, Yanlin Liu, Ling Zhao, Shaozhi Fu

Summary: Local hypoxia is a common feature of solid tumors. In this study, a biocompatible bacteria/nanoparticles biohybrid platform was developed to target breast tumors. The results showed that the biohybrid was able to effectively colonize hypoxic tumors, increasing drug accumulation and reducing toxic side-effects.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Review Oncology

Bacteria in cancer therapy: A new generation of weapons

Jun Ying Fan, Yuan Huang, Yi Li, Tobias Achu Muluh, Shao Zhi Fu, Jing Bo Wu

Summary: Tumors pose a significant threat to human life and health. Conventional therapies such as radiotherapy and chemotherapy have limitations in their effectiveness, including high toxicity to normal cells and the risk of drug resistance. Bacterial anti-tumor immunotherapy has emerged as a promising alternative, utilizing bacteria to target and colonize tumor tissues, triggering anti-tumor immune responses to effectively eliminate tumor cells.

CANCER MEDICINE (2022)

Article Pharmacology & Pharmacy

Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma

Susu Xiao, Yu Wang, Wenqiong Ma, Ping Zhou, Biqiong Wang, Zhouxue Wu, Qian Wen, Kang Xiong, Yanlin Liu, Shaozhi Fu

Summary: A thermosensitive hydrogel composite was developed for inhibiting ascites of hepatocellular carcinoma through intraperitoneal injection, showing promising anti-tumor effects.

DRUG DELIVERY (2022)

Review Pharmacology & Pharmacy

Injectable hydrogels as drug delivery platform for in-situ treatment of malignant tumor

Qian Ma, Qiang Li, Xin Cai, Ping Zhou, Zhouxue Wu, Biqiong Wang, Wenqiong Ma, Shaozhi Fu

Summary: Cancer treatment is a highly researched field in biomedical science. Injectable hydrogels, used as drug carriers, have been widely applied in cancer therapy, and biodegradable hydrogels also have great potential in inhibiting tumor recurrence and metastasis.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)

Article Nanoscience & Nanotechnology

Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy

Yao Chen, Shuya Liu, Yin Liao, Hanshan Yang, Zhuo Chen, Yuru Hu, Shaozhi Fu, Jingbo Wu

Summary: In this study, albumin-modified gold nanoparticles (Alb-GNPs) were prepared and their radiosensitizing effects and biotoxicity in human non-small-cell lung carcinoma tumor-bearing mice models were observed. The prepared nanoparticles (Alb-GNPs) showed excellent colloidal stability and biocompatibility with a mean size of 205.06 +/- 1.03 nm. Clone formation experiments demonstrated that Alb-GNPs exerted excellent radiosensitization with a higher sensitization enhancement ratio (SER) of 1.432 compared to X-ray alone. Alb-GNPs could accumulate favorably in tumors and their combination with radiotherapy exhibited a greater radiosensitizing effect and anti-tumor activity. Additionally, no toxicity or abnormal irritating response was observed with the application of Alb-GNPs.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2023)

Article Engineering, Biomedical

GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model

Jie Dai, Jianmei Li, Yuqin Zhang, Qian Wen, Yun Lu, Yu Fan, Fancai Zeng, Zhiyong Qian, Yan Zhang, Shaozhi Fu

Summary: The Bif@PAu-NPs hybrid effectively targets hypoxic regions in tumors to achieve precise photothermal therapy and stimulate an immune response through immunogenic cell death. The inclusion of GM-CSF enhances the immune response, leading to long-term anti-tumor immunity and suppression of tumor growth.

BIOMATERIALS RESEARCH (2023)

No Data Available